State Street’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.52M Sell
1,508,634
-432,243
-22% -$1.58M ﹤0.01% 2898
2025
Q1
$8.38M Buy
1,940,877
+386,366
+25% +$1.67M ﹤0.01% 2640
2024
Q4
$4.97M Buy
1,554,511
+94,744
+6% +$303K ﹤0.01% 2981
2024
Q3
$4.17M Buy
1,459,767
+9,090
+0.6% +$26K ﹤0.01% 3047
2024
Q2
$4.06M Sell
1,450,677
-1,117
-0.1% -$3.13K ﹤0.01% 3014
2024
Q1
$4.12M Buy
1,451,794
+51,249
+4% +$146K ﹤0.01% 3005
2023
Q4
$5.73M Buy
1,400,545
+90,389
+7% +$370K ﹤0.01% 2887
2023
Q3
$4.17M Buy
1,310,156
+27,262
+2% +$86.7K ﹤0.01% 3009
2023
Q2
$4.26M Buy
1,282,894
+5,594
+0.4% +$18.6K ﹤0.01% 3075
2023
Q1
$2.72M Sell
1,277,300
-1,207,063
-49% -$2.57M ﹤0.01% 3226
2022
Q4
$6.68M Buy
2,484,363
+437,076
+21% +$1.18M ﹤0.01% 2903
2022
Q3
$6.63M Sell
2,047,287
-4,123,302
-67% -$13.4M ﹤0.01% 2922
2022
Q2
$30.1M Buy
6,170,589
+1,750,534
+40% +$8.54M ﹤0.01% 1961
2022
Q1
$33.7M Sell
4,420,055
-980,805
-18% -$7.47M ﹤0.01% 2020
2021
Q4
$49.9M Buy
5,400,860
+1,341,450
+33% +$12.4M ﹤0.01% 1802
2021
Q3
$57.8M Sell
4,059,410
-185,271
-4% -$2.64M ﹤0.01% 1711
2021
Q2
$70.5M Buy
4,244,681
+3,861,302
+1,007% +$64.2M ﹤0.01% 1586
2021
Q1
$6.99M Buy
383,379
+28,550
+8% +$520K ﹤0.01% 2902
2020
Q4
$2.67M Buy
354,829
+95,815
+37% +$722K ﹤0.01% 3246
2020
Q3
$995K Buy
259,014
+64,493
+33% +$248K ﹤0.01% 3438
2020
Q2
$747K Buy
194,521
+22,733
+13% +$87.3K ﹤0.01% 3479
2020
Q1
$555K Buy
171,788
+7,028
+4% +$22.7K ﹤0.01% 3423
2019
Q4
$792K Buy
164,760
+38,917
+31% +$187K ﹤0.01% 3448
2019
Q3
$827K Buy
125,843
+2,837
+2% +$18.6K ﹤0.01% 3435
2019
Q2
$593K Buy
+123,006
New +$593K ﹤0.01% 3487